These conclusions support the current guidelines on the treatment of desmoid tumours (http://www.nccn.org) (Casali and Blay, 2010).
Altogether, our data strongly support the current guidelines that suggest screening anorectum and oropharyngeal samples based on sexual history in addition to urethral tests [ 4- 6, 15, 16, 18].
Taken together, our results support the current guidelines for the use of HbA1c for the diagnosis of diabetes and suggest that current clinical cut points should be interpreted similarly in whites, blacks, and Hispanics.
The current literature does not seem to support the current guidelines as there is no evidence to suggest that a delay in cannulation of grafts will improve graft survival and patency.
In conclusion, the current literature does not seem to support the current guidelines as there is no evidence to suggest that a delay in cannulation of PTFE grafts will improve graft survival and patency.
These data support the current guidelines of monitoring children clinically while on ATX treatment without obtaining baseline or ongoing laboratory or ECG evaluations unless a specific clinical presentation is cause for concern (i.e., jaundice, pruritus, or dark urine).
Although no significant association was found between western pattern and ESCC, the results from three patterns (western, healthy, and drinker/alcohol) support the current guidelines and recommendations of increasing consumption of fruits and vegetables, and reducing consumption of red and processed meat and lowering intake of alcohol for primary prevention of oesophageal cancer.
Overall, our findings are consistent with previous meta-analyses in showing elevated total and breast cancer mortality associated with higher BMI and support the current guidelines for breast cancer survivors to stay as lean as possible within the normal range of body weight [ 4], for overweight women to avoid weight gain during treatment and for obese women to lose weight after treatment [ 119].
Collectively, our findings suggest that the efficacy of anticoagulation in clinical trials may translate into real world clinical practice and support the current guideline recommendations of warfarin treatment as an anticoagulation approach for the prevention of recurrent stroke in patients with atrial fibrillation.
